Relugolix combo therapy could reduce HMB-related anaemia, distress
13 Aug 2020
byRoshini Claire Anthony
Relugolix combination therapy (relugolix-CT) comprising relugolix and estradiol (E2)/norethindrone acetate (NETA) could improve anaemia in women with heavy menstrual bleeding (HMB) due to uterine fibroids, according to pooled results of the phase III LIBERTY* 1 and 2 trials presented at ESHRE 2020.
Relugolix combo therapy could reduce HMB-related anaemia, distress
13 Aug 2020